Maven Brands - CEO, Darcy Bomford.
CEO, Darcy Bomford.
Source: Maven Brands.
  • Maven Brands (MJ) has closed the first tranche of a previously announced non-brokered private placement for gross proceeds of $242,359.56
  • The company issued 1,346,442 units exerciseable for two years
  • Proceeds will be used to complete work for the launch of the company’s craft cannabis processing program
  • Maven Brands is a licensed cannabis producer preparing to launch a program to provide path-to-market services for micro-cultivators
  • Maven Brands Inc. (MJ) opened trading at C$0.21 per share

Maven Brands (MJ) has closed the first tranche of a non-brokered private placement for gross proceeds of $242,359.56.

The company issued 1,346,442 units. Each unit consists of one common share and one-half of one warrant, with each whole warrant exercisable to purchase one additional common share at a price of $0.27 for a period of two years.

Maven Brands paid $6,004.80 in cash commissions and 33,360 finder’s warrants.

Proceeds will be used to complete work for the launch of the company’s craft cannabis processing program and for general corporate purposes.

Maven is a licensed producer of cannabis preparing to launch a program to provide path-to-market services for micro-cultivators. The program will offer a full suite of in-house processing services to the craft cannabis community.

Maven Brands Inc. (MJ) opened trading at C$0.21 per share.

More From The Market Online

Buzz on the Bullboards: Oil shock, biotech breakthroughs and new tech

Global equities lurched from rally to rout since the U.S.–Israel strikes on Iran ignited a regional war and shutdown of the Strait of Hormuz.

Cannabix’s Marijuana Breath Test hits the market

Cannabix (CSE:BLO) begins the commercial rollout for its Marijuana Breath Test, including deliveries to customers across numerous industries.
Stock Talk Cannabis Report image of cannabis plants and VW van

StockTalk | Cannabis Report: Relaunching business into the spring

Ascend Wellness Holdings, Inc. (CSE: AAWH.U / OTCQX:AAWH), a multi-state, vertically integrated cannabis operator, has relaunched...

Quit smoking with psychedelics? A new frontier for treatment — and investors

A new Johns Hopkins study found that a single dose of psilocybin, combined with therapy, helped smokers stay cigarette free at six months.